No Benefit for Lopinavir –Ritonavir in Severe COVID-19

Treatment with the HIV combination drug lopinavir-ritonavir did not accelerate recovery or improve mortality rates among hospitalized patients with severe coronavirus disease 2019 (COVID-19), a trial in the New England Journal of Medicine reported.
Source: JAMA - Category: General Medicine Source Type: research